Translational challenges of remote ischemic conditioning in ischemic stroke - a systematic review.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
08 2021
Historique:
revised: 20 04 2021
received: 11 02 2021
accepted: 19 05 2021
pubmed: 17 6 2021
medline: 27 1 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

Remote ischemic conditioning (RIC) has well-established cardioprotective effects in preclinical studies and promising results in preclinical stroke research. Effective translation from preclinical studies to clinical trials has yet to be accomplished, perhaps because of the use of multiple applications of RIC (e.g., pre-, per-, or post-conditioning) in preclinical studies by both invasive and non-invasive protocols, some of which not clinically applicable. Our systematic review conformed to PRISMA guidelines and addressed differences in clinically relevant RIC applications and outcomes between preclinical and clinical studies. We retrieved a total of 30 studies (8 human; 22 animal) that met the inclusion criteria of testing clinically relevant procedures; namely, non-invasive and per- or post-conditioning protocols. Per-conditioning was applied in 6 animal and 3 human studies, post-conditioning was applied in 16 animal and 5 human studies, and both conditioning methods were applied in 2 animal studies. Application of RIC varied between human and animal studies regarding initiation, duration, repetition, and number of limbs included. Study designs did not systematically apply blinding, randomization, or placebo controls. On only a few occasions did preclinical studies include animals with clinically relevant comorbidities. Clinical trials were challenged by not completing the intended number of RIC cycles or addressing this deficit in the data analysis. Consistency and transferability of methods used for positive animal studies and subsequent human studies are essential for the optimal translation of results. Consensus on preclinical and clinical RIC procedures should be reached for a full understanding of the possible beneficial effects of RIC treatment in stroke.

Identifiants

pubmed: 34133841
doi: 10.1002/acn3.51405
pmc: PMC8351389
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1720-1729

Informations de copyright

© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Neurochem Int. 2020 May;135:104690
pubmed: 31981607
CNS Neurosci Ther. 2018 Jun;24(6):519-527
pubmed: 29399973
Neural Regen Res. 2018 Sep;13(9):1585-1593
pubmed: 30127119
Nat Rev Neurol. 2015 Dec;11(12):698-710
pubmed: 26585977
Metab Brain Dis. 2017 Dec;32(6):1805-1818
pubmed: 28707040
Nat Rev Cardiol. 2016 Apr;13(4):193-209
pubmed: 26843289
Transl Stroke Res. 2016 Oct;7(5):358-67
pubmed: 27534542
J Integr Neurosci. 2019 Dec 30;18(4):377-385
pubmed: 31912695
BMC Neurosci. 2015 Dec 29;16:97
pubmed: 26715469
Cochrane Database Syst Rev. 2018 Jul 05;7:CD012503
pubmed: 29974450
J Stroke Cerebrovasc Dis. 2018 Apr;27(4):831-838
pubmed: 29395650
Brain Res. 2014 Oct 24;1586:173-83
pubmed: 25124744
Dis Model Mech. 2014 Dec;7(12):1321-33
pubmed: 25481012
Brain Res. 2018 May 1;1686:94-100
pubmed: 29462606
Exp Physiol. 2019 Mar;104(3):278-294
pubmed: 30597638
Behav Brain Res. 2015 Aug 1;289:1-8
pubmed: 25907740
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3328-3335
pubmed: 30201456
Behav Brain Res. 2018 Mar 15;340:87-93
pubmed: 27780723
J Mol Neurosci. 2016 Apr;58(4):424-31
pubmed: 26852332
Circulation. 2016 Aug 23;134(8):574-5
pubmed: 27550967
J Neurosci. 2019 Sep 25;39(39):7778-7789
pubmed: 31427395
Int J Mol Med. 2014 Oct;34(4):957-66
pubmed: 25092271
Neuroreport. 2016 May 4;27(7):469-75
pubmed: 27031871
Transl Stroke Res. 2014 Aug;5(4):484-90
pubmed: 24385308
Stroke. 2011 Oct;42(10):2960-2
pubmed: 21836089
Restor Neurol Neurosci. 2015;33(3):369-79
pubmed: 25868435
Stroke Res Treat. 2012;2012:374098
pubmed: 23326759
Stroke. 2017 May;48(5):1412-1415
pubmed: 28265014
Neurol Res. 2018 Mar;40(3):182-188
pubmed: 29369005
Ann Clin Transl Neurol. 2018 Jun 06;5(7):850-856
pubmed: 30009202
Aging Dis. 2015 Nov 17;6(6):406-17
pubmed: 26618042
Int J Surg. 2014 Oct;12(10):1093-9
pubmed: 25152442
Front Cell Neurosci. 2018 Oct 29;12:383
pubmed: 30420796
Ann Clin Transl Neurol. 2019 Jan 15;6(2):310-323
pubmed: 30847363
J Neurosci Res. 2015 Aug;93(8):1250-7
pubmed: 25787695
Ann Clin Transl Neurol. 2020 Jun;7(6):972-979
pubmed: 32472628
PLoS One. 2020 Jan 16;15(1):e0227624
pubmed: 31945776
Ann Clin Transl Neurol. 2019 Jan 16;6(2):364-372
pubmed: 30847368
J Am Heart Assoc. 2019 Dec 3;8(23):e013572
pubmed: 31747864
Stroke. 2014 Jan;45(1):159-67
pubmed: 24203849
Biomed Res Int. 2017;2017:6891645
pubmed: 28473987
Neurobiol Dis. 2013 Jun;54:216-24
pubmed: 23313315

Auteurs

Line Fuglsang Hansen (LF)

Department of Neurology, Neurovascular Research Unit, Herlev Gentofte Hospital, Copenhagen, Denmark.
Department of Anesthesiology and Intensive Care, Holbaek Hospital, Holbaek, Denmark.

Nicholine S K Nielsen (NSK)

Department of Neurology, Neurovascular Research Unit, Herlev Gentofte Hospital, Copenhagen, Denmark.

Laura Cathrine Christoffersen (LC)

Department of Neurology, Neurovascular Research Unit, Herlev Gentofte Hospital, Copenhagen, Denmark.

Christina Kruuse (C)

Department of Neurology, Neurovascular Research Unit, Herlev Gentofte Hospital, Copenhagen, Denmark.
Department. of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH